Antimicrobial resistance in the community is a problem and requires sensible use of antibiotics. This program will review data on emerging antimicrobial resistance in outpatient practice and discuss the implications of resistance in the community. This program will also promote good antibiotic stewardship in the outpatient setting.
This talk will review common challenges in infectious diseases encountered in the outpatient setting. They will include clinical encounters that encompass preventive strategies, interpretation of diagnostic tests and the optimal evaluation of both undifferentiated fever and fever in the returning traveler. Finally, Dr. Sax will present the latest updates on the Zika virus epidemic and discuss the precautions to be taken by pregnant women and returning travelers from affected regions.
The ease of international travel, climate change, and emerging infections increase the risk that patients will present with febrile illnesses acquired abroad. This talk will discuss appropriate pre-travel evaluation and infection prevention counseling, as well as the appropriate early detection, evaluation, and management of the febrile traveler. The faculty will use interactive clinical vignettes to highlight the most important differential diagnoses and introduce the audience to emerging infections across the globe.
Hear the latest developments in the war against antimicrobial resistance and recommendations for treating outpatient infections.
This program aims to under issues related to the changing epidemiology and challenges of treating infections caused by C. difficile, B. pertussis, and N. gonorrhoeae. It will also discuss recent changes in adult vaccination requirements.
The aim of this program is to discuss the challenges with treating and diagnosing chronic idiopathic urticarial (CIU) as well as discussing the epidemiology, physiologic and socioeconomic sequelae, treatment strategies, and the utility of adjunctive or novel therapies for CIU.
In this Clinical Coffee Break, Dr. Gio Baracco discusses the latest information available about the Zika virus and what primary care providers should know in order to help protect their patients from this potentially serious infection.
Chronic Lyme disease or post-treatment Lyme disease syndrome affects about 10-20% of patients treated for Lyme disease. In this activity, learn to address some common misconceptions associated with this condition, including identifying the correct symptoms and treatments. Dr. Flaherty will take you through frequently asked questions about managing chronic Lyme disease, and discuss strategies to avoid misdiagnosis and the prescription of unnecessary antibiotics and treatments based on subjective symptoms.
More than 2 billion people in the world have Latent TB infection (LTBI), a condition in which the individual harbors the bacterium, Mycobacterium tuberculosis but is neither symptomatic nor contagious. Currently, there are estimated to be about 10 to 15 million Americans with LTBI. Although they are asymptomatic and not infectious, up to 10% are at risk of progression to active disease each year, depending on their risk factors and co-morbidities. As such, the identification and treatment of LTBI is essential to reduce the risk of progression to active tuberculosis disease. This activity will review what modalities exist to diagnose LTBI, which groups are at high risk and the role of preventive chemotherapy. Further, Dr. Dowling will discuss any new approaches for therapy and management on the horizon.
Lyme disease is an infectious bacterial disease transmitted via tick bites. According to the CDC, Lyme disease is the most commonly reported vectorborne illness in the United States. This activity will provide on update on Lyme disease screening and will discuss in detail the steps involved in correctly diagnosing and confirming Lyme disease. The activity will also discuss treatment options for acute disease and detail strategies for avoiding Lyme disease.
Clostridium difficile infections (CDI) are on the rise in the United States and recently have been recognized as a major public health concern. Learn about the pathogenesis of and risk factors associated with C. difficile infections. This activity also discusses ways and means to handle newly recognized public health concerns like community-associated CDI. Finally, this activity provides an update on the diagnosis and treatment guidelines for acute and severe CDI episodes.